High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome

Singh, 2011, Uveal melanoma: trends in incidence, treatment, and survival, Ophthalmology, 118, 1881, 10.1016/j.ophtha.2011.01.040

Seregard, 2007, Uveal malignant melanoma: management options—brachytherapy, Clinical ophthalmic oncology, 10.1016/B978-1-4160-3167-3.50046-2

Pe'er, 2012, Ruthenium-106 brachytherapy, Dev Ophthalmol, 49, 27, 10.1159/000328254

Bergman, 2005, Ruthenium brachytherapy for uveal melanoma, 1979–2003: survival and functional outcomes in the Swedish population, Ophthalmology, 112, 834, 10.1016/j.ophtha.2004.11.038

Mossbock, 2007, Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106, Strahlenther Onkol, 183, 571, 10.1007/s00066-007-1734-x

Papageorgiou, 2011, Predicting local control of choroidal melanomas following 106 Ru plaque brachytherapy, Br J Ophthalmol, 95, 166, 10.1136/bjo.2009.176198

Damato, 2005, Local tumor control after 106Ru brachytherapy of choroidal melanoma, Int J Radiat Oncol Biol Phys, 63, 385, 10.1016/j.ijrobp.2005.02.017

Lax, 1991, Dosimetry of 106Ru eye applicators with a p-type silicon detector, Phys Med Biol, 36, 963, 10.1088/0031-9155/36/7/005

AJCC, 2010, Cancer staging manual, 7

Kaiserman, 2009, Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas, Br J Ophthalmol, 93, 1167, 10.1136/bjo.2009.157701

Sanchez-Reyes, 1998, Monte Carlo calculation of the dose distributions of two 106Ru eye applicators, Radiother Oncol, 49, 191, 10.1016/S0167-8140(98)00095-4

Brualla, 2012, Comment on Monte Carlo calculation of the dose distributions of two (1)(0)(6)Ru eye applicators [Radiother Oncol 49 (1998) 191–196], Radiother Oncol, 104, 267, 10.1016/j.radonc.2012.07.006

Kaulich, 2005, Clinical quality assurance for 106Ru ophthalmic applicators, Radiother Oncol, 76, 86, 10.1016/j.radonc.2005.05.001

Seregard, 1997, Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma, Acta Ophthalmol Scand, 75, 148, 10.1111/j.1600-0420.1997.tb00112.x

Avery, 2008, Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study, Arch Ophthalmol, 126, 207, 10.1001/archophthalmol.2007.50

Liu, 2013, High dose rate versus low dose rate brachytherapy for oral cancer--a meta-analysis of clinical trials, PLoS One, 8, e65423, 10.1371/journal.pone.0065423